Search

Author/Creator Raha, Sohini

1. Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD‐11 trial. Issue 10 (8th July 2021)

Authors:
Frias, Juan P.; Bonora, Enzo; Nevárez Ruiz, Luis; Hsia, Stanley H.; Jung, Heike; Raha, Sohini; Cox, David A.; Bethel, M. Angelyn; Konig, Manige
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 23:Issue 10(2021)
Page Start:
2279
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial. (31st December 2023)

Authors:
Ferrannini, Giulia; Maldonado, Juan M.; Raha, Sohini; Rao-Melacini, Purnima; Khatun, Rutaba; Atisso, Charles; Shurzinske, Linda; Gerstein, Hertzel C.; Rydén, Lars; Bethel, M. Angelyn
Journal:
Scandinavian cardiovascular journal
Issue:
Volume 57:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD‐11. Issue 12 (14th September 2021)

Authors:
Frias, Juan P.; Bonora, Enzo; Cox, David A.; Bethel, M. Angelyn; Kwan, Anita Y.M.; Raha, Sohini; Malik, Raleigh E.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 23:Issue 12(2021)
Page Start:
2819
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗